Press Release
Category Added in a WPeMatico Campaign
-
Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress
SAN MATEO, Calif., June 8, 2026 /PRNewswire/ — Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies,…
Read More » -
Mercuryo Claims 60th Place in Sifted 100: Southern Europe Leaderboard, Recognising the Region’s most Innovative High-Growth Startups
LONDON, June 8, 2026 /PRNewswire/ — Global payments infrastructure platform Mercuryo has been recognised by Sifted, a startup news service backed…
Read More » -
/R E P E A T — Media Advisory – Minister Hodgson to participate in the Montreal Council on Foreign Relations forum/
MONTREAL, June 4, 2026 /CNW/ – The Minister of Energy and Natural Resources, the Honourable Tim Hodgson, will deliver a speech…
Read More » -
Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial
TAIPEI, June 8, 2026 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that Foresee’s oral ALDH2 activator, mirivadelgat, has been selected to…
Read More » -
Yiren Digital Announces Increase in Beneficial Ownership by Mr. Ning Tang Following Controlling Shareholder Restructuring
BEIJING, June 8, 2026 /PRNewswire/ — Yiren Digital Ltd. (NYSE: YRD) (“Yiren Digital” or the “Company”), a leading fintech company…
Read More » -
Nuvion Joins Circle Payments Network to Bring Global, Near-Instant Payments to Global Businesses
MIAMI, June 8, 2026 /PRNewswire/ — Nuvion, the AI-powered global banking and cross-border payments platforms built on fiat and stablecoins…
Read More » -
Business Wire4 weeks ago
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1
Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at…
Read More » -
Business Wire4 weeks ago
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1
Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at…
Read More » -
INVT Unveils “Smart + Net-Zero” Strategy and New Product Portfolio at 2026 Global Launch Event
SUZHOU, China, June 8, 2026 /PRNewswire/ — Leading industrial automation and energy solution supplier INVT successfully held its Global Strategy…
Read More » -
Innodisk Showcases Full Qualcomm Dragonwing Edge AI Lineup at Computex 2026, Spanning Dragonwing IQ8 Through IQ10
TAIPEI, June 8, 2026 /PRNewswire/ — Innodisk, a leading global AI solution provider, showcases the full breadth of its collaboration…
Read More »